Storage stability depends on peptide type and handling quality
WADA 2026 Prohibited List Status (Section S0) BPC-157 is named explicitly on the World Anti-Doping Agency 2025 and 2026 Prohibited Lists under section S0 (Non-Approved Substances), prohibited at all times in and out of competition
Conclusions Recent advances in this field have highlighted the importance of GST activities and the role that these enzymes play in diverse cellular processes as well as in conferring resistance to chemotherapy
BPC-157 is a stable gastric pentadecapeptide with protective effects on the GI tract, muscle, tendon, and nerve tissue, making it a potential multi-system healing agent. Sikiric et al., Current Pharmaceutical Design What Makes BPC-157 Unique
This DSIP nasal spray is supplied for in-vitro laboratory research, is not intended for human or veterinary use, is not a drug, supplement or sleep aid, and has not been evaluated by the FDA for the research-chemical context